Wells Fargo & Company Pep Gen Inc. Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Pep Gen Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 7,471 shares of PEPG stock, worth $13,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,471
Previous 5,052
47.88%
Holding current value
$13,223
Previous $43,000
34.88%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PEPG
# of Institutions
59Shares Held
24.7MCall Options Held
0Put Options Held
15K-
Ra Capital Management, L.P. Boston, MA10.7MShares$18.9 Million0.66% of portfolio
-
Rtw Investments, LP New York, NY3.19MShares$5.65 Million0.2% of portfolio
-
Viking Global Investors LP1.48MShares$2.62 Million0.02% of portfolio
-
Suvretta Capital Management, LLC New York, NY1.17MShares$2.08 Million0.19% of portfolio
-
Black Rock Inc. New York, NY1.04MShares$1.84 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $41.8M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...